Bank of New York Mellon Corp Acquires 15,309 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

Bank of New York Mellon Corp grew its stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 3.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 451,102 shares of the company’s stock after buying an additional 15,309 shares during the quarter. Bank of New York Mellon Corp owned 0.12% of LifeStance Health Group worth $2,215,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of LFST. Vanguard Group Inc. boosted its holdings in LifeStance Health Group by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 7,668,966 shares of the company’s stock valued at $47,318,000 after acquiring an additional 95,197 shares during the period. Jennison Associates LLC boosted its stake in shares of LifeStance Health Group by 0.7% during the first quarter. Jennison Associates LLC now owns 1,938,323 shares of the company’s stock valued at $11,959,000 after purchasing an additional 12,629 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in shares of LifeStance Health Group by 0.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 744,617 shares of the company’s stock worth $5,830,000 after purchasing an additional 5,112 shares during the last quarter. Swiss National Bank increased its stake in shares of LifeStance Health Group by 25.4% in the first quarter. Swiss National Bank now owns 186,800 shares of the company’s stock worth $1,153,000 after buying an additional 37,800 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in LifeStance Health Group by 17.6% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 184,190 shares of the company’s stock valued at $1,136,000 after buying an additional 27,605 shares during the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on LFST. Barclays cut their price target on shares of LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating on the stock in a report on Friday, August 9th. UBS Group reduced their price target on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a report on Thursday, August 15th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $8.25.

LifeStance Health Group Stock Down 1.3 %

Shares of NASDAQ LFST opened at $6.85 on Tuesday. The firm has a fifty day simple moving average of $5.93 and a two-hundred day simple moving average of $6.04. The firm has a market capitalization of $2.62 billion, a PE ratio of -14.27 and a beta of 1.22. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 0.20. LifeStance Health Group, Inc. has a 12 month low of $4.64 and a 12 month high of $9.20.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01. The company had revenue of $312.30 million during the quarter, compared to the consensus estimate of $305.85 million. LifeStance Health Group had a negative net margin of 13.05% and a negative return on equity of 10.51%. LifeStance Health Group’s revenue was up 20.3% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.13) earnings per share. Equities analysts expect that LifeStance Health Group, Inc. will post -0.24 earnings per share for the current year.

Insider Transactions at LifeStance Health Group

In related news, insider Ann Varanakis sold 5,269 shares of LifeStance Health Group stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $6.28, for a total transaction of $33,089.32. Following the sale, the insider now directly owns 263,007 shares in the company, valued at $1,651,683.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 6.60% of the company’s stock.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.